$AIM SEC Filings

Filed On	Filing
26 Oct 2026	Form 4: Equels Thomas K, Director Bought 31,675 shares ($5.07K)
23 Oct 2026	Form 4: Equels Thomas K, Director Bought 31,250 shares ($5.09K)
30 Sep 2026	ARS
30 Sep 2026	Proxy statement: annual meeting on November 17, 2026 say-on-pay vote
18 Sep 2026	Form 4: Equels Thomas K, Director Bought 24,000 shares ($4.99K)
17 Sep 2026	Form 4: Equels Thomas K, Director Bought 11,000 shares ($2.31K)
16 Sep 2026	Form 4: Equels Thomas K, Director Bought 22,000 shares ($4.86K)
15 Sep 2026	Form 4: Equels Thomas K, Director Bought 5,900 shares ($1.29K)
14 Sep 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities From September 8, 2026 to September 9, 2026, AIM ImmunoTech Inc. (the “Company”) entered into a total of two exchange agreements (the “Exchange Agreements”) and, for each, a corresponding partitioned promissory note (together, the “Parti...
10 Sep 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities THE EXCHANGE CONTEMPLATED HEREIN IS INTENDED TO COMPORT WITH THE REQUIREMENTS OF SECTION 3(a)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED.
04 Sep 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
11 Aug 2026	8-K: Regulation FD Disclosure
10 Aug 2026	8-K: Results of Operations and Financial Condition
07 Aug 2026	10-Q
06 Aug 2026	8-K: Entry into a Material Definitive Agreement; Shareholder Director Nominations
05 Aug 2026	8-K: Termination of a Material Definitive Agreement
16 Jul 2026	8-K: Submission of Matters to a Vote of Security Holders
09 Jul 2026	S-8
25 Jun 2026	Proxy statement: special meeting on July 15, 2026
24 Jun 2026	424B3

Comments